Islet autoantibody level distributions in type 1 diabetes and their association with genetic and clinical characteristics

Positivity for islet autoantibodies is used for diagnosis of type 1 diabetes. However, the importance of the autoantibody level at diagnosis of type 1 diabetes is not clear. Here, we assessed the association of glutamate decarboxylase (GADA), islet antigen-2 (IA-2A) and zinc transporter 8 (ZnT8A) autoantibody levels, measured using radiobinding assays, on genetic and clinical characteristics at diagnosis of 1536 participants with diabetes who were positive for these autoantibodies. We show that GADA and IA-2A levels had bimodal distributions, but ZnT8A level did not. The comparison of genetic and clinical characteristics between high and low level categories showed high GADA level was associated with older age at diagnosis, female sex and HLA-DR3-DQ2, whereas high IA-2A level was associated with younger age of diagnosis, ZnT8A positivity and HLA-DR4-DQ8. We replicated our findings in an independent cohort of 427 people with type 1 diabetes where autoantibodies were measured using enzyme-linked immunosorbent assays. In conclusion, Islet autoantibody levels provide additional information over positivity in type 1 diabetes at diagnosis. The bimodality of islet autoantibody levels highlights the novel aspect of heterogeneity of type 1 diabetes which may have implications on prediction, treatment and prognosis.

follows a chi-squared distribution on 5-2 = 3 degrees of freedom. Both analyses yielded LRT GADA = 345, p<2x10 -16 ). We used the nadir value between the two peaks to divide the 1 4 1 bimodal distribution of the autoantibody levels into two groups (low vs. high levels) for the 1 4 2 subsequent analysis. The nadir value for GADA levels was 452 DK U/ml. All participants 1 4 3 with a GADA level lower than this value were grouped into a low level GADA group (mean 1 4 4 level 180.3, SD +/-118.4, 711/1268 (56%)) and the participants with a GADA level above or  Higher GADA levels were associated with later age at diagnosis of type 1 diabetes, 1 5 0 female sex, and HLA-DR3-DQ2.

5 1
To assess the association of bimodal GADA levels to clinical features at diagnosis, we 1 5 2 compared the clinical features between the people with low level (lower mode) and high level 1 5 3 (higher mode) GADA as defined above (Table 1) number of other islet autoantibodies and other islet autoantibody levels were similar between 1 6 2 the two GADA level groups. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
Higher IA-2A levels were associated with earlier age at diagnosis of type 1 diabetes and 1 6 4 HLA DR4-DQ8 and ZnT8A positivity.

6 5
We next compared the clinical features of low and high IA-2A level groups to assess 1 6 6 association of bimodal IA-2A level distribution to clinical features at diagnosis. (Table 2). Contrary to GADA, those in the higher level IA-2A group were diagnosed earlier compared  Table 2). They were more likely to be multiple ZnT8A (78% vs. 52%, P=2x10 -16 ) and more likely to have higher ZnT8A levels (median were more likely to have HLA DR4-DQ8 (68% vs. 51%, P=5x10 -7 ). The presentation HbA1c and BMI, parent with diabetes) ( Table 2).

7 6
ZnT8A level at diagnosis was not associated with age at diagnosis of type 1 diabetes 1 7 7 To assess the association of ZnT8A level to clinical features at diagnosis, we divided 906   positive (71% vs. 55% with three autoantibodies) and more likely to be positive for IA-2A (86% vs. 76% P=1.5x10 -4 ) (ESM Table 3) and GADA (83% vs. 74% P=0.002). Similar results for the lack of association of ZnT8A level to age at diagnosis were observed with 1 8 7 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) linear regression analysis of log ZnT8A level to age at diagnosis (β=-0.57, 95% CI -1.2,0.08, and c-terminal epitopes, and multiple autoantibodies positivity (24). We did not observe the 2 3 6 association of high GADA level with multiple autoantibodies, but we did observe the 2 3 7 association of higher IA-2A level with multiple autoantibodies. These data suggest that 2 3 8 affinity, the difference in epitopes, and the presence of other autoantibodies may also 2 3 9 contribute towards bimodality.  The underlying reason for this observation is not clear. However, it is not due to change in 2 5 0 overall humoral immunity due to age as we see the opposite effect of autoantibody levels on 2 5 1 age with different autoantibodies. In contrast to our findings in type 1 diabetes, studies of 2 5 2 LADA have shown that higher GADA level is associated with early age of onset. This may . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted August 8, 2021. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity (which was not certified by peer review) The copyright holder for this prep this version posted August 8, 2021. ; https://doi.org/10.1101/2021.08.04.21261472 doi: medRxiv preprint